We are live on ! Find out more
DARE icon

Dare Bioscience

30 hedge funds and large institutions have $3.73M invested in Dare Bioscience in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.16% more ownership

Funds ownership: 0%0.16% (+0.16%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

3% less funds holding

Funds holding: 3130 (-1)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

54% less capital invested

Capital invested by funds: $8.07M → $3.73M (-$4.33M)

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
6
Increased
8
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change

DARE Hedge Fund Activity: Q4 2016 in Review

30 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2016, worth a combined $3.73M — down 54% from $8.07M a quarter earlier.

Fund positioning in DARE was balanced in Q4 2016: 6 funds opened new positions, 6 closed out, 8 added to existing stakes and 5 trimmed.

The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $47.1K. The largest seller was Granahan Investment Management, exiting entirely with an estimated $755K sold.

  • 30 institutional investors held Dare Bioscience (DARE) as of Q4 2016, down from 31 in Q3 2016.
  • Funds reported $3.73M of Dare Bioscience stock for Q4 2016, down 54% quarter-over-quarter.
  • 6 funds opened new Dare Bioscience positions in Q4 2016 and 6 closed out, a net change of 0 holders.
  • The largest Dare Bioscience buyer in Q4 2016 was A.R.T. Advisors, an estimated $47.1K added.
  • The largest Dare Bioscience seller in Q4 2016 was Granahan Investment Management, an estimated $755K sold.

Based on aggregated 13F filings for Q4 2016.